Condition: Prostate Adenocarcinoma · Prostate Cancer · Sponsor: Case Comprehensive Cancer Center
This study aims to compare the novel single-port robotic partial prostatectomy to High-intensity focused ultrasound (HIFU) in patients with low to intermediate risk localized prostate cancer. These interventions have become acceptable focal therapies prevalent with beneficial oncologic outcomes and therefore need to be examined further.
This description comes directly from the study's public registry record.
Jihad Kaouk, MD · 216-444-2976 · kaoukj@ccf.org
Always discuss trial participation with your own doctor first.
| Glickman Urological & Kidney Institute, Cleveland Clinic Foundation, Case Comprehensive Cancer Center | Cleveland, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05610852